% Expired Patents = 100.0

Forward Citations = 81

Loading Chart...

7 inventors (with patents filed for the assignee):

Samuel Ray Denmeade (7 out of 25 patents)

John Tod Isaacs (7 out of 22 patents)

Hans Lilja (2 out of 11 patents)

4. Xiong Fu (1 out of 4 patents)

5. John K Lynch (1 out of 3 patents)

6. Jeff Hutchison (1 out of 4 patents)

7. Kevin Kunnen (1 out of 5 patents)

8 patents: Sort by Forward Citations

1. 9446141 - Methods of producing cancer compounds (2016-09-20),

2. 8957016 - Tumor activated prodrugs (2015-02-17),

3. 8822406 - Tumor activated prodrugs (2014-09-02),

4. 8669231 - Activation of peptide prodrugs by hK2 (2014-03-11),

5. 7906477 - Activation of peptide prodrugs by hK2 (2011-03-15),

6. 7767648 - Tissue specific prodrugs (2010-08-03),

7. 7635682 - Tumor activated prodrugs (2009-12-22),

8. 7468354 - Tissue specific prodrugs (2008-12-23),

Company Overview

Genspera, Inc. is a biotechnology company focused on developing and commercializing novel treatments for cancer. Their lead product candidate, AzaSite, is a targeted therapy designed to selectively kill cancer cells while leaving healthy cells unharmed. Genspera's innovative approach has the potential to revolutionize cancer treatment and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#84 in San Antonio, TX

#2,279 in Texas

#35,924 in US

San Antonio, TX, United States of America

Genspera, Inc.

Forward Citations = 81

7 inventors:

Samuel Ray Denmeade (7 out of 25 patents)

John Tod Isaacs (7 out of 22 patents)

Hans Lilja (2 out of 11 patents)

4. Xiong Fu (1 out of 4 patents)

5. John K Lynch (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genspera, Inc.. Retrieved from https://idiyas.com/company/genspera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]